Yorktown Management & Research Company’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-137,300
| Closed | -$1.15M | – | 275 |
|
|
2021
Q4 | $1.15M | Buy |
137,300
+24,100
| +21% | +$201K | 0.77% | 19 |
|
|
2021
Q3 | $841K | Buy |
113,200
+56,600
| +100% | +$421K | 0.63% | 28 |
|
|
2021
Q2 | $385K | Buy |
56,600
+7,400
| +15% | +$50.3K | 0.3% | 141 |
|
|
2021
Q1 | $505K | Hold |
49,200
| – | – | 0.42% | 72 |
|
|
2020
Q4 | $344K | Sell |
49,200
-2,000
| -4% | -$14K | 0.31% | 157 |
|
|
2020
Q3 | $418K | Buy |
51,200
+8,200
| +19% | +$66.9K | 0.39% | 91 |
|
|
2020
Q2 | $297K | Buy |
+43,000
| New | +$297K | 0.27% | 193 |
|